The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A.   Ackland1 S.P.   Gardiner E.   Walkom C.C.   Sakoff1 J.A.  

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

An Approach for the Rational Design of New Antituberculosis Agents

By  

Current Drug Targets, Vol. 2, Iss. 4, 2001-12 ,pp. : 427-437

Bentham Science Publishers

Access to resources Recommend Favorite

Halogen bonding for rational drug design and new drug discovery

By Lu Yunxiang   Liu Yingtao   Xu Zhijian   Li Haiying   Liu Honglai   Zhu Weiliang  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 375-383

Informa Healthcare

Access to resources Recommend Favorite

Rational Design, Synthesis and In Vitro Evaluation of Three New Alkylating Steroidal Esters

By  

Medicinal Chemistry, Vol. 2, Iss. 6, 2006-11 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite

The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of Vaccines

By  

Current Pharmaceutical Design, Vol. 7, Iss. 11, 2001-07 ,pp. : 1015-1037

Bentham Science Publishers

Access to resources Recommend Favorite